Banque Cantonale Vaudoise’s BioTelemetry, Inc. BEAT Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,931	Closed	-$500K	–	1215
2020 Q4	$500K	Buy	6,931 +895	+15%	+$46.9K	0.03%	497
2020 Q3	$275K	Buy	6,036 +74	+1%	+$3.09K	0.02%	604
2020 Q2	$269K	Buy	5,962 +53	+0.9%	+$2.38K	0.02%	571
2020 Q1	$228K	Sell	5,909 -541	-8%	-$24.9K	0.02%	592
2019 Q4	$299K	Buy	+6,450	New	+$279K	0.02%	617

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Banque Cantonale Vaudoise's BEAT Position: Q1 2021 in Review

Banque Cantonale Vaudoise sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 6,931 shares — an estimated $500K sold.

Banque Cantonale Vaudoise first reported a position in BEAT in Q4 2019 and held it in 5 quarters. The position peaked at $500K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Banque Cantonale Vaudoise reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Banque Cantonale Vaudoise sold 6,931 BioTelemetry, Inc. shares in Q1 2021, an estimated $500K.
Banque Cantonale Vaudoise first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 5 quarters.
Banque Cantonale Vaudoise's BioTelemetry, Inc. position peaked at $500K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2021, filed 11 May 2021.